Northern Trust Corp Bolt Biotherapeutics, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 40,895 shares of BOLT stock, worth $20,447. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,895
Previous 40,895
-0.0%
Holding current value
$20,447
Previous $26,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BOLT
# of Institutions
36Shares Held
18.7MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA3.81MShares$1.91 Million0.16% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.52MShares$1.76 Million0.38% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$1.38 Million0.12% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$945,7330.96% of portfolio
-
Nan Fung Group Holdings LTD Central, K31.17MShares$583,4760.63% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $18.8M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...